-logo.jpg "AmerisourceBergen logo")
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company's Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNYSE:ABC
CUSIP03073E10
Phone610-727-7000
Debt
Debt-to-Equity Ratio1.39
Current Ratio0.94
Quick Ratio0.51
Price-To-Earnings
Trailing P/E Ratio14.92
Forward P/E Ratio13.54
P/E Growth1.28
Sales & Book Value
Annual Sales$153.14 billion
Price / Sales0.12
Cash Flow$8.5248 per share
Price / Cash10.29
Book Value$9.47 per share
Price / Book9.26
Profitability
EPS (Most Recent Fiscal Year)$5.88
Net Income$364.48 million
Net Margins0.69%
Return on Equity48.65%
Return on Assets3.80%
Miscellaneous
Employees20,000
Outstanding Shares216,360,000
Market Cap$17.74 billion
AmerisourceBergen (NYSE:ABC) Frequently Asked Questions
What is AmerisourceBergen's stock symbol?
AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."
How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?
AmerisourceBergen announced a quarterly dividend on Thursday, August 9th. Shareholders of record on Monday, August 20th will be given a dividend of $0.38 per share on Tuesday, September 4th. This represents a $1.52 dividend on an annualized basis and a yield of 1.73%. The ex-dividend date is Friday, August 17th. View AmerisourceBergen's Dividend History.
How were AmerisourceBergen's earnings last quarter?
AmerisourceBergen Corp. (NYSE:ABC) posted its quarterly earnings results on Thursday, August, 2nd. The company reported $1.54 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.46 by $0.08. The firm had revenue of $43.14 billion for the quarter, compared to analyst estimates of $43.05 billion. AmerisourceBergen had a return on equity of 48.65% and a net margin of 0.69%. The business's quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.43 earnings per share. View AmerisourceBergen's Earnings History.
When is AmerisourceBergen's next earnings date?
What price target have analysts set for ABC?
15 equities research analysts have issued 1 year price targets for AmerisourceBergen's stock. Their predictions range from $88.00 to $115.00. On average, they expect AmerisourceBergen's share price to reach $101.7143 in the next twelve months. This suggests a possible upside of 16.0% from the stock's current price. View Analyst Price Targets for AmerisourceBergen.
What is the consensus analysts' recommendation for AmerisourceBergen?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 6 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AmerisourceBergen.
Who are some of AmerisourceBergen's key competitors?
Who are AmerisourceBergen's key executives?
AmerisourceBergen's management team includes the folowing people:
- Mr. Steven H. Collis, Chairman, Pres & CEO (Age 57)
- Mr. Tim G. Guttman, Exec. VP & CFO (Age 59)
- Mr. John G. Chou, Exec. VP and Chief Legal & Bus. Officer (Age 62)
- Dr. Robert P. Mauch, Exec. VP and Group Pres of Pharmaceutical Distribution & Strategic Global Sourcing (Age 51)
- Mr. James D. Frary, Exec. Officer (Age 46)
Has AmerisourceBergen been receiving favorable news coverage?
News coverage about ABC stock has trended somewhat positive on Monday, Accern Sentiment reports. The research firm identifies positive and negative media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. AmerisourceBergen earned a news impact score of 0.11 on Accern's scale. They also assigned news headlines about the company an impact score of 47.33 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future. View Recent Headlines for AmerisourceBergen.
Who are AmerisourceBergen's major shareholders?
AmerisourceBergen's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (5.81%), Vulcan Value Partners LLC (2.31%), FMR LLC (2.03%), Burgundy Asset Management Ltd. (1.25%), Wells Fargo & Company MN (1.24%) and Beutel Goodman & Co Ltd. (1.04%). Company insiders that own AmerisourceBergen stock include Dale Danilewitz, Gina Clark, Henry Wadsworth Mcgee III, John G Chou, Kathy H Gaddes, Lazarus Krikorian, Peyton R Howell, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View Institutional Ownership Trends for AmerisourceBergen.
Which institutional investors are selling AmerisourceBergen stock?
ABC stock was sold by a variety of institutional investors in the last quarter, including Westpac Banking Corp, Artisan Partners Limited Partnership, First Quadrant L P CA, Mackay Shields LLC, Janus Henderson Group PLC, Bridgewater Associates LP, BlueMountain Capital Management LLC and Wells Fargo & Company MN. Company insiders that have sold AmerisourceBergen company stock in the last year include Dale Danilewitz, John G Chou, Kathy H Gaddes, Lazarus Krikorian, Peyton R Howell, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View Insider Buying and Selling for AmerisourceBergen.
Which institutional investors are buying AmerisourceBergen stock?
ABC stock was purchased by a variety of institutional investors in the last quarter, including Fort Washington Investment Advisors Inc. OH, Millennium Management LLC, BlackRock Inc., Unigestion Holding SA, J. L. Bainbridge & Co. Inc., FMR LLC, Beutel Goodman & Co Ltd. and Tavio Capital LLC. View Insider Buying and Selling for AmerisourceBergen.
How do I buy shares of AmerisourceBergen?
Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is AmerisourceBergen's stock price today?
One share of ABC stock can currently be purchased for approximately $87.72.
How big of a company is AmerisourceBergen?
AmerisourceBergen has a market capitalization of $17.74 billion and generates $153.14 billion in revenue each year. The company earns $364.48 million in net income (profit) each year or $5.88 on an earnings per share basis. AmerisourceBergen employs 20,000 workers across the globe.
How can I contact AmerisourceBergen?
AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]
MarketBeat Community Rating for AmerisourceBergen (NYSE ABC)
MarketBeat's community ratings are surveys of what our community members think about AmerisourceBergen and other stocks. Vote "Outperform" if you believe ABC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days.
